Levofloxacin for the prevention of febrile episodes in non-Hodgkin lymphoma patients treated with CHOP plus rituximab in a randomized controlled trial.
This randomized, single-blind, placebo-controlled trial assessed the efficacy of levofloxacin prophylaxis in 80 non-Hodg...